This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Dishman Carbogen Amcis Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
DCAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.3 pts less than Nifty Microcap 250 and 8.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dishman Carbogen Amcis has submitted its Q2 FY26 and H1 FY26 results. On a consolidated basis, quarterly revenue from operations fell to Rs 652.65 crore from Rs 789.04 crore a year ago (down about 17%), but net profit after tax jumped to Rs 65.27 crore from Rs 33.09 crore (nearly doubled). For the half year, consolidated revenue rose modestly to Rs 1,360.70 crore from Rs 1,312.82 crore, while the company swung from a Rs 44.48 crore loss to an Rs 88.68 crore profit. Consolidated operating margin expanded sharply to 22.81% in Q2 from 18.82% a year earlier, reflecting better cost control and lower exceptional items. Standalone results, however, remained weak with a Q2 net loss of Rs 13.61 crore versus a Rs 14.25 crore profit last year and H1 standalone loss of Rs 10.93 crore. The auditor (T R Chadha & Co LLP) issued an unqualified review but flagged an emphasis of matter regarding the goodwill treatment — the Board extended goodwill amortization to 99 years from January 1, 2015, leaving Rs 584.25 crore of goodwill on the books.
Positive surprise on consolidated profitability and margin expansion despite top-line pressure may support the stock in the short term, though weak standalone performance and the unusual goodwill amortization policy remain areas for investor scrutiny.
| Q2 FY26 | Q2 FY25 | Change | |
|---|---|---|---|
| Revenue | ₹652.7 Cr | ₹789.0 Cr | −17.3% |
| Operating profit | ₹22.43 Cr | ₹38.43 Cr | −41.6% |
| Profit after tax | ₹65.27 Cr | ₹33.09 Cr | +97.2% |
| EBITDA margin | 22.8% | 18.3% | +4.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.